HIGHLIGHTS
- who: Qun Zhang from the First Affiliated Hospital of China Medical University, China have published the research: Case report: A colorectal cancer patient with microsatellite instability-high and MSH2 germline mutation failed to respond to anti-PD-1 immunotherapy, in the Journal: (JOURNAL)
- how: For quantitative analysis the authors used ipp software to analyze the density of CD8 and PDL1.
SUMMARY
Despite the remarkable efficacy of anti-PD1 therapy in advanced MSI-H/dMMR CRC patients, nearly half of MSI-H/ dMMR CRC patients do not respond to it. Studies have . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.